Pertinax Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 4
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $447K
Latest Deal Amount
  • Investors
  • 6

Pertinax General Information

Description

Developer of antimicrobial technologies intended to be used in medical devices. The company's products can be incorporated into a wide range of medical device material substrates, including polymers and coatings, protecting them from infection.

Contact Information

Website
www.pertinaxpharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Supplies
Primary Office
  • Future Space, UWE North Gate
  • Filton Road
  • Bristol BS34 8RB
  • England, United Kingdom
+44 07775 000000

Pertinax Timeline

2018201920202021
Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pertinax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC 21-Mar-2019 $447K 00.000 00.000 Completed Generating Revenue
6. Grant 16-Jan-2019 00.000 Completed Generating Revenue
5. Early Stage VC 23-Jan-2018 00.00 00.000 00.000 Completed Generating Revenue
4. Seed Round 15-Mar-2017 00000 00.000 00.000 Completed Startup
3. Early Stage VC 11-Apr-2016 00000 00000 00.000 Completed Startup
2. Grant 11-Mar-2016 $768K Completed Startup
1. Grant 23-Apr-2015 $37.1K Completed Startup
To view Pertinax’s complete valuation and funding history, request access »

Pertinax Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
C Ordinary 00,000 00.000000 000.00 000.00 00 000.00 00.000
A Ordinary 00,000 00.000000 000.00 000.00 00 000.00 00.000
A Ordinary 39,000 $0.000132 $21.1 $21.1 1x $21.1 11.66%
A Ordinary 36,958 $0.000132 $15.14 $15.14 1x $15.14 11.05%
To view Pertinax’s complete cap table history, request access »

Pertinax Executive Team (3)

Name Title Board Seat Contact Info
Michele Barbour Ph.D Chief Executive Officer & Founder
Stuart Gibson Board Member & Chief Financial Officer
To view Pertinax’s complete executive team members history, request access »

Pertinax Board Members (6)

Name Representing Role Since
Isabel Dodd Ph.D Mercia Asset Management Board Member 000 0000
Michele Redmond Pertinax Board Member 000 0000
Rosalind Darby Pertinax Board Member 000 0000
Simon Hubbert Self Chairman 000 0000
Stuart Gibson Pertinax Board Member & Chief Financial Officer 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Pertinax Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pertinax Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Perivoli Innovations Trust Other Minority 000 0000 000000 0
Innovation 4 Growth Corporation 000 0000 000000 0
Mercia Asset Management Venture Capital Minority 000 0000 000000 0
Innovate UK Government 000 0000 000000 0
SETsquared Partnership Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial